quantrifat

RGEN

quantrifat 업데이트됨   
NASDAQ:RGEN   Repligen Corporation
First Half 2019 Highlights--
Revenue increased by 42% year-over-year, and 42% organically, to $131.3 million
GAAP income from operations increased 580 bps to 16.9% of revenue
Adjusted (non-GAAP) income from operations increased 870 bps to 27.2% of revenue
GAAP fully-diluted EPS increased to $0.34 compared to $0.14 for the first half of 2018

Adjusted (non-GAAP) fully-diluted EPS increased to $0.59 compared to $0.29 for the first half of 2018

Buy Zone: $81.45 to $77.96
Stop loss: Daily close below $76.70
Target: $99+
액티브 트레이드:
adjust the stop loss::-- daily close below $77.33 area.
액티브 트레이드:
sorry for the typing error... stop loss is daily close below 76.33 area
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.